Media Centre

Find out more about the latest news at Virtus Health, including medical breakthroughs in fertility treatment, growth within our network, and research papers.

Contact Us for comment on recent developments in the industry or interview requests.

Virtus Grows Revenue and Australian Market Share Despite Weak Local Market Conditions

Highlights

  • Revenue increased by 12.9% to $114.5 million
  • EBITDA increased by 2.6% to $32.8 million
  • Australian segment EBITDA increased by 2.2% to $36.8 million
  • Increased Australian Assisted Reproductive Services (ARS) market share despite sector contraction
  • International operations contribute $10.4 million to revenue
  • Day Hospital and Specialist Diagnostics continue to deliver growth

Key Financial Results

 

Virtus Health Subsidiary Sims Clinic Completes Acquisition of Second Irish Fertility Clinic for €6 Million

Sydney, Australia – Further to the announcement to ASX made on 24 December 2014, Virtus Health (“Virtus”, ASX: VRT), Australia’s largest IVF provider, announces that its 70% owned subsidiary, Sims IVF Clinic, Ireland’s largest IVF provider, has completed the acquisition of Irish fertility centre, the HARI clinic from the Rotunda Hospital in Dublin for €6 million.

Virtus Health Subsidiary Sims IVF Clinic to Acquire Second Irish Fertility Clinic for €6 Million

Sydney, Australia – Virtus Health (“Virtus”, ASX: VRT), Australia’s largest IVF provider, today announced that its 70% owned subsidiary, Sims Clinic has agreed to acquire an Irish fertility centre, the HARI clinic from the Rotunda Hospital in Dublin for €6 million. Virtus expects the transaction will be completed on 31 December 2014.

Virtus Health Opens New Fertility Centre In Singapore

Sydney, Australia – Virtus Health (“Virtus”, ASX: VRT), Australia’s largest IVF provider, is pleased to announce it has opened its first Virtus branded Fertility Centre in Singapore.

Virtus Health Acquires a Majority Stake in Tasmanian IVF Provider, TasIVF for $16M

Sydney, Australia – Virtus Health (“Virtus”, ASX: VRT) Australia’s largest IVF provider today announced it has acquired a 70% share of TasIVF Pty Ltd (“TasIVF”).

The transaction value is $16.0 million on a cash free debt free basis and has been satisfied from existing cash resources and a drawdown of $8m from the group’s bank facilities. For the year to 30 June 2014, TasIVF normalised earnings would have increased Virtus' basic earnings per share by approximately 1.24 cents.

Australian First: New genetic testing set to improve access and outcomes for IVF patients

In an Australian first, Virtus Health comprising Melbourne IVF, Queensland Fertility Group and IVFAustralia has introduced karyomapping, a new genetic test that will significantly improve access to treatment and the chance of a live birth for couples wishing to avoid the transmission of a serious genetic disorder to their children.

Patients who know they are carriers of a genetic disease, for example cystic fibrosis, can have their embryos tested using karyomapping and preimplantation genetic diagnosis (PGD).

Virtus Health Acquires IVF Sunshine Coast Clinic

Sydney, Australia – Virtus Health (“Virtus”, ASX: VRT) Australia’s largest IVF provider today announced it has acquired the remaining 80% share of IVF Sunshine Coast in Queensland, taking full ownership of the clinic.

Virtus Health Comments on Employers Offering Egg Freezing for Female Staff

Virtus Health, the leading provider of fertility treatment and egg freezing in Australia, described the news of Facebook and Apple offering female staff egg freezing to preserve their fertility as recognition by two of the world’s most innovative companies, that this technology has come of age and is a real option for fertility preservation.
 

Virtus Health Full Year Financial Results FY2014

Pro-forma net profit after tax (NPAT) grew 17.2% on the previous year to $32 million, from $27.3 million; pro-forma revenue rose 6.7% on the previous year to $199.9 million, from $187.3 million. Actual (or statutory) revenue from ordinary activities increased 7.9% to $201.2 million from $186.6 million while statutory net profit attributable to the owners of Virtus Health Limited tripled to $30.9million, from $10.1 million.

Virtus Health Expands into Asia

Sydney, Australia – Virtus Health (“Virtus”, ASX: VRT), Australia’s largest IVF provider, is pleased to announce it has commenced development of its first international, Virtus branded fertility centre, in Singapore.

Virtus Health has joined together with three leading Singaporean fertility specialists to establish the ‘Virtus Fertility Centre’ at the Scotts Medical Centre in Singapore's CBD.

Career Opportunities

Interested in joining our team? Read about our current opportunities for fertility specialists.
Find out more...

© Virtus Group 2015